Tag: Shenda Baker

Synspira’s cystic fibrosis treatment PAAG15A gets FDA orphan designation

pharmanewsdaily- October 14, 2018

Synspira has been given the orphan designation status by the US Food and Drug Administration (FDA) for poly (acetyl, arginyl) glucosamine (PAAG15A) for cystic fibrosis ... Read More